The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
Zydus has developed an innovative Semaglutide Injection (15 mg/3 ml) in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
Under the deal, Quiver will receive an undisclosed advance payment and research support
Subscribe To Our Newsletter & Stay Updated
